Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Quality of Life Following Major Laparoscopic or Open Pancreatic Resection.

Torphy RJ, Chapman BC, Friedman C, Nguyen C, Bartsch CG, Meguid C, Ahrendt SA, McCarter MD, Del Chiaro M, Schulick RD, Edil BH, Gleisner A.

Ann Surg Oncol. 2019 Sep;26(9):2985-2993. doi: 10.1245/s10434-019-07449-x. Epub 2019 Jun 21.

PMID:
31228131
2.

Discrimination of low- and high-grade appendiceal mucinous neoplasms by targeted sequencing of cancer-related variants.

LaFramboise WA, Pai RK, Petrosko P, Belsky MA, Dhir A, Howard PG, Becich MJ, Holtzman MP, Ahrendt SA, Pingpank JF, Zeh HJ, Dhir R, Bartlett DL, Choudry HA.

Mod Pathol. 2019 Jul;32(8):1197-1209. doi: 10.1038/s41379-019-0256-2. Epub 2019 Apr 8.

PMID:
30962504
3.

Pleuropulmonary Recurrence Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Appendiceal Pseudomyxoma Peritonei.

Beane JD, Wilson GC, Sutton JM, Shuai Y, Ramalingam L, Jones HL, Pingpank JF 2nd, Holtzman MP, Zureikat AJ, Ahrendt SA, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2019 May;26(5):1429-1436. doi: 10.1245/s10434-018-07091-z. Epub 2019 Jan 8.

PMID:
30623341
4.

Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups.

Amblard I, Mercier F, Bartlett DL, Ahrendt SA, Lee KW, Zeh HJ, Levine EA, Baratti D, Deraco M, Piso P, Morris DL, Rau B, Tentes AAK, Tuech JJ, Quenet F, Akaishi E, Pocard M, Yonemura Y, Lorimier G, Delroeux D, Villeneuve L, Glehen O, Passot G; PSOGI and BIG RENAPE working groups.

Eur J Surg Oncol. 2018 Sep;44(9):1378-1383. doi: 10.1016/j.ejso.2018.04.023. Epub 2018 Jun 19.

PMID:
30131104
5.

Impact of genomic profiling on the treatment and outcomes of patients with advanced gastrointestinal malignancies.

Dhir M, Choudry HA, Holtzman MP, Pingpank JF, Ahrendt SA, Zureikat AH, Hogg ME, Bartlett DL, Zeh HJ, Singhi AD, Bahary N.

Cancer Med. 2017 Jan;6(1):195-206. doi: 10.1002/cam4.992. Epub 2016 Dec 28.

6.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Adolescent and Young Adults with Peritoneal Metastases.

Dhir M, Ramalingam L, Shuai Y, Pakrafter S, Jones HL, Hogg ME, Zureikat AH, Holtzman MP, Ahrendt SA, Bahary N, Pingpank JF, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2017 Apr;24(4):875-883. doi: 10.1245/s10434-016-5689-y. Epub 2016 Dec 19.

PMID:
27995449
7.

Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell Carcinoids.

Radomski M, Pai RK, Shuai Y, Ramalingam L, Jones H, Holtzman MP, Ahrendt SA, Pingpank JF, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2016 Dec;23(13):4338-4343. Epub 2016 Jul 11.

PMID:
27401448
8.

Oncologic Risk Stratification Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendiceal Carcinomatosis.

Wagner PL, Austin F, Zenati M, Jaech A, Mavanur A, Ramalingam L, Jones HL, Holtzman MP, Ahrendt SA, Zureikat AH, Pingpank JF, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2016 May;23(5):1587-93. doi: 10.1245/s10434-015-5037-7. Epub 2016 Jan 7.

PMID:
26744106
9.

An integrated genome-wide approach to discover deregulated microRNAs in non-small cell lung cancer: Clinical significance of miR-23b-3p deregulation.

Begum S, Hayashi M, Ogawa T, Jabboure FJ, Brait M, Izumchenko E, Tabak S, Ahrendt SA, Westra WH, Koch W, Sidransky D, Hoque MO.

Sci Rep. 2015 Aug 28;5:13236. doi: 10.1038/srep13236.

10.

Preoperative inflammatory biomarkers and neurovegetative symptoms in peritoneal carcinomatosis patients.

Low CA, Bovbjerg DH, Jenkins FJ, Ahrendt SA, Choudry HA, Holtzman MP, Jones HL, Pingpank JF, Ramalingam L, Zeh HJ, Zureikat AH, Bartlett DL.

Brain Behav Immun. 2014 Nov;42:65-8. doi: 10.1016/j.bbi.2014.06.019. Epub 2014 Jul 6.

11.

GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival.

Singhi AD, Davison JM, Choudry HA, Pingpank JF, Ahrendt SA, Holtzman MP, Zureikat AH, Zeh HJ, Ramalingam L, Mantha G, Nikiforova M, Bartlett DL, Pai RK.

Hum Pathol. 2014 Aug;45(8):1737-43. doi: 10.1016/j.humpath.2014.04.018. Epub 2014 May 8.

PMID:
24925222
12.

Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade.

Davison JM, Choudry HA, Pingpank JF, Ahrendt SA, Holtzman MP, Zureikat AH, Zeh HJ, Ramalingam L, Zhu B, Nikiforova M, Bartlett DL, Pai RK.

Mod Pathol. 2014 Nov;27(11):1521-39. doi: 10.1038/modpathol.2014.37. Epub 2014 Mar 14.

13.

Loss of SMAD4 protein expression is associated with high tumor grade and poor prognosis in disseminated appendiceal mucinous neoplasms.

Davison JM, Hartman DA, Singhi AD, Choudry HA, Ahrendt SA, Zureikat AH, Ramalingam L, Nikiforova M, Pai RK.

Am J Surg Pathol. 2014 May;38(5):583-92. doi: 10.1097/PAS.0000000000000194.

PMID:
24618609
14.

Extensive cytoreductive surgery for appendiceal carcinomatosis: morbidity, mortality, and survival.

Wagner PL, Austin F, Maduekwe U, Mavanur A, Ramalingam L, Jones HL, Holtzman MP, Ahrendt SA, Zureikat AH, Pingpank JF, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2013 Apr;20(4):1056-62. doi: 10.1245/s10434-012-2791-7. Epub 2013 Mar 2.

15.

Aggressive locoregional management of recurrent peritoneal sarcomatosis.

Baumgartner JM, Ahrendt SA, Pingpank JF, Holtzman MP, Ramalingam L, Jones HL, Zureikat AH, Zeh HJ 3rd, Bartlett DL, Choudry HA.

J Surg Oncol. 2013 Mar;107(4):329-34. doi: 10.1002/jso.23232. Epub 2013 Feb 5.

PMID:
23386388
16.

Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin.

Wagner PL, Austin F, Sathaiah M, Magge D, Maduekwe U, Ramalingam L, Jones HL, Holtzman MP, Ahrendt SA, Zureikat AH, Pingpank JF, Zeh HJ 3rd, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2013 Feb;20(2):506-14. doi: 10.1245/s10434-012-2627-5. Epub 2012 Sep 1.

17.

Serum microRNA biomarkers for detection of non-small cell lung cancer.

Hennessey PT, Sanford T, Choudhary A, Mydlarz WW, Brown D, Adai AT, Ochs MF, Ahrendt SA, Mambo E, Califano JA.

PLoS One. 2012;7(2):e32307. doi: 10.1371/journal.pone.0032307. Epub 2012 Feb 28.

18.

Genetic and epigenetic analysis of erbB signaling pathway genes in lung cancer.

Hoque MO, Brait M, Rosenbaum E, Poeta ML, Pal P, Begum S, Dasgupta S, Carvalho AL, Ahrendt SA, Westra WH, Sidransky D.

J Thorac Oncol. 2010 Dec;5(12):1887-93. doi: 10.1097/JTO.0b013e3181f77a53. Erratum in: J Thorac Oncol. 2011 Feb;6(2):409.

19.

Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer.

Franko J, Gusani NJ, Holtzman MP, Ahrendt SA, Jones HL, Zeh HJ 3rd, Bartlett DL.

Ann Surg Oncol. 2008 Nov;15(11):3065-72. doi: 10.1245/s10434-008-0105-x. Epub 2008 Aug 19.

PMID:
18712450
20.

Indications for non-transplant surgery in primary sclerosing cholangitis.

Domajnko B, Ahrendt SA.

HPB (Oxford). 2005;7(4):292-7. doi: 10.1080/13651820500273392.

21.

The case against preoperative biliary drainage with pancreatic resection.

Johnson RC, Ahrendt SA.

HPB (Oxford). 2006;8(6):426-31. doi: 10.1080/13651820600840124.

22.

Surgical approaches to strictures in primary sclerosing cholangitis.

Ahrendt SA.

J Gastrointest Surg. 2008 Mar;12(3):423-5. Epub 2007 Oct 20. Review.

PMID:
17952519
23.

Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer.

Khorana AA, Ahrendt SA, Ryan CK, Francis CW, Hruban RH, Hu YC, Hostetter G, Harvey J, Taubman MB.

Clin Cancer Res. 2007 May 15;13(10):2870-5.

24.

Vascular endothelial growth factor and DPC4 predict adjuvant therapy outcomes in resected pancreatic cancer.

Khorana AA, Hu YC, Ryan CK, Komorowski RA, Hostetter G, Ahrendt SA.

J Gastrointest Surg. 2005 Sep-Oct;9(7):903-11.

PMID:
16137582
25.

The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.

Hu Y, McDermott MP, Ahrendt SA.

Clin Cancer Res. 2005 Apr 1;11(7):2502-9.

27.

Thymidylate synthase expression predicts the response to 5-fluorouracil-based adjuvant therapy in pancreatic cancer.

Hu YC, Komorowski RA, Graewin S, Hostetter G, Kallioniemi OP, Pitt HA, Ahrendt SA.

Clin Cancer Res. 2003 Sep 15;9(11):4165-71.

28.

Translational research in lung cancer.

Chen Y, Okunieff P, Ahrendt SA.

Semin Surg Oncol. 2003;21(3):205-19. Review.

PMID:
14508854
29.

Screening of homologous recombination gene polymorphisms in lung cancer patients reveals an association of the NBS1-185Gln variant and p53 gene mutations.

Medina PP, Ahrendt SA, Pollan M, Fernandez P, Sidransky D, Sanchez-Cespedes M.

Cancer Epidemiol Biomarkers Prev. 2003 Aug;12(8):699-704.

30.
31.

p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study.

Ahrendt SA, Hu Y, Buta M, McDermott MP, Benoit N, Yang SC, Wu L, Sidransky D.

J Natl Cancer Inst. 2003 Jul 2;95(13):961-70.

PMID:
12837832
32.

Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.

Harden SV, Tokumaru Y, Westra WH, Goodman S, Ahrendt SA, Yang SC, Sidransky D.

Clin Cancer Res. 2003 Apr;9(4):1370-5.

33.

Molecular detection approaches for smoking associated tumors.

Hu YC, Sidransky D, Ahrendt SA.

Oncogene. 2002 Oct 21;21(48):7289-97. Review.

34.

Surgical management of pancreatic cancer.

Ahrendt SA, Pitt HA.

Oncology (Williston Park). 2002 Jun;16(6):725-34; discussion 734, 736-8, 740, 743. Review.

35.

Cystic pancreatic neuroendocrine tumors: is preoperative diagnosis possible?

Ahrendt SA, Komorowski RA, Demeure MJ, Wilson SD, Pitt HA.

J Gastrointest Surg. 2002 Jan-Feb;6(1):66-74.

PMID:
11986020
36.

Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study.

Ahrendt SA, Yang SC, Wu L, Roig CM, Russell P, Westra WH, Jen J, Brock MV, Heitmiller RF, Sidransky D.

J Thorac Cardiovasc Surg. 2002 Mar;123(3):466-73; discussion 473-4.

37.

Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung.

Ahrendt SA, Decker PA, Alawi EA, Zhu Yr YR, Sanchez-Cespedes M, Yang SC, Haasler GB, Kajdacsy-Balla A, Demeure MJ, Sidransky D.

Cancer. 2001 Sep 15;92(6):1525-30.

PMID:
11745231
38.
39.

Surgical therapy of iatrogenic lesions of biliary tract.

Ahrendt SA, Pitt HA.

World J Surg. 2001 Oct;25(10):1360-5. Review.

PMID:
11596904
40.

Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers.

Sanchez-Cespedes M, Decker PA, Doffek KM, Esteller M, Westra WH, Alawi EA, Herman JG, Demeure MJ, Sidransky D, Ahrendt SA.

Cancer Res. 2001 Mar 1;61(5):2092-6.

41.

Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers.

Sanchez-Cespedes M, Ahrendt SA, Piantadosi S, Rosell R, Monzo M, Wu L, Westra WH, Yang SC, Jen J, Sidransky D.

Cancer Res. 2001 Feb 15;61(4):1309-13.

42.

Cholangiocarcinoma.

Ahrendt SA, Nakeeb A, Pitt HA.

Clin Liver Dis. 2001 Feb;5(1):191-218. Review.

PMID:
11218916
43.

p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer.

Ahrendt SA, Rashid A, Chow JT, Eisenberger CF, Pitt HA, Sidransky D.

J Hepatobiliary Pancreat Surg. 2000;7(4):426-31.

PMID:
11180865
44.

Immunohistochemistry and molecular detection of nodal micrometastases in pancreatic cancer.

Brown HM, Ahrendt SA, Komorowski RA, Doffek KM, Wilson SD, Demeure MJ.

J Surg Res. 2001 Feb;95(2):141-6.

PMID:
11162037
45.

Microsatellite instability at AAAG repeat sequences in respiratory tract cancers.

Xu L, Chow J, Bonacum J, Eisenberger C, Ahrendt SA, Spafford M, Wu L, Lee SM, Piantadosi S, Tockman MS, Sidransky D, Jen J.

Int J Cancer. 2001 Jan 15;91(2):200-4.

46.

p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer.

Ahrendt SA, Brown HM, Komorowski RA, Zhu YR, Wilson SD, Erickson BA, Ritch PS, Pitt HA, Demeure MJ.

Surgery. 2000 Oct;128(4):520-30.

PMID:
11015084
47.

Biliary tract surgery.

Ahrendt SA.

Curr Gastroenterol Rep. 1999 Apr;1(2):107-15. Review.

PMID:
10980936
48.

Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer.

Ahrendt SA, Chow JT, Yang SC, Wu L, Zhang MJ, Jen J, Sidransky D.

Cancer Res. 2000 Jun 15;60(12):3155-9.

49.

Microsatellite instability at selected tetranucleotide repeats is associated with p53 mutations in non-small cell lung cancer.

Ahrendt SA, Decker PA, Doffek K, Wang B, Xu L, Demeure MJ, Jen J, Sidransky D.

Cancer Res. 2000 May 1;60(9):2488-91.

50.

Iron deficiency diminishes gallbladder neuronal nitric oxide synthase.

Swartz-Basile DA, Goldblatt MI, Blaser C, Decker PA, Ahrendt SA, Sarna SK, Pitt HA.

J Surg Res. 2000 May 1;90(1):26-31.

PMID:
10781371

Supplemental Content

Loading ...
Support Center